Dipyridamole Tablet, Film Coated
FDA Label NDC 65841-662

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Dipyridamole (NDC 65841-662). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 65841-662-01 in bottle of 100 tablets

Dipyridamole Tablets USP, 25 mg

Rx only

100 tablets

ZYDUS

Dipyridamole Tablets, 25 mg (Dipyridamoletablets Figure 01)

Dipyridamole Tablets, 25 mg (Dipyridamoletablets Figure 01)

NDC 65841-663-01 in bottle of 100 tablets

Dipyridamole Tablets USP, 50 mg

Rx only

100 tablets

ZYDUS

Dipyridamole Tablets, 50 mg (Dipyridamoletablets Figure 04)

Dipyridamole Tablets, 50 mg (Dipyridamoletablets Figure 04)

NDC 65841-664-01 in bottle of 100 tablets

Dipyridamole Tablets USP, 75 mg

Rx only

100 tablets

ZYDUS

Dipyridamole Tablets, 75 mg (Dipyridamoletablets Figure 03)

Dipyridamole Tablets, 75 mg (Dipyridamoletablets Figure 03)

* Please review the disclaimer below.